Challenges in Treating Polycystic Ovarian Syndrome
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
Anovulation is a significant challenge for reproductive age women. The most common endocrinologic cause of this is PCOS. With the help of Dr. Sam Thatcher, pioneer in IVF technology and director of the Center for Applied Reproductive Science, we explore the exciting new possibilities and not-so-new controversies that exist with regard to treatment for PCOS patients. Helpful information about the medical therapies available for patients with PCOS such as clomid, metformin and oral contraceptives are presented. He also disputes the ‘one size fits all” theory when it comes to the care of women with PCOS. Reference material: 1. Legro, RS et al. Clomiphene, metformin or both for fertility in PCOS. N Engl J Med 2007; 356:551-56
Overview
Anovulation is a significant challenge for reproductive age women. The most common endocrinologic cause of this is PCOS. With the help of Dr. Sam Thatcher, pioneer in IVF technology and director of the Center for Applied Reproductive Science, we explore the exciting new possibilities and not-so-new controversies that exist with regard to treatment for PCOS patients. Helpful information about the medical therapies available for patients with PCOS such as clomid, metformin and oral contraceptives are presented. He also disputes the ‘one size fits all” theory when it comes to the care of women with PCOS. Reference material: 1. Legro, RS et al. Clomiphene, metformin or both for fertility in PCOS. N Engl J Med 2007; 356:551-56
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Implementing a Multidisciplinary Approach to Heart Failure: Patient Identification and Treatment Using Novel Device Therapy
Bridging Distances in PAH: Bringing Best Practices to the People Through Telementoring
Updates From the 7th World Symposium Task Force
Integrating Guideline Directed Medical Therapy for Patients with CKD and T2D
Pulmonary Hypertension Management: Practice Trends and Updates
Distinguishing Between Anti-PD-1 Agents in ESCC Combination Therapies
Respiratory Dysfunction in Neuromuscular Disorders: Evaluating Symptoms
Bladders, Breakthroughs, and Bold New Therapies: Key Updates at AUA 2025
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?